HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Meningioma

Meningioma

Meningiomas, while usually benign, pose significant challenges in cancer research due to their diverse biological behavior and potential for recurrence. Researchers are delving into the molecular mechanisms underlying their formation and progression, aiming to identify novel therapeutic targets. Advanced imaging techniques aid in accurate diagnosis and monitoring of tumor growth, while innovative surgical approaches and radiation therapies strive to minimize damage to surrounding brain tissue. Additionally, clinical trials explore the efficacy of targeted therapies and immunotherapies in managing meningiomas, offering hope for improved outcomes and quality of life for patients. Collaborative efforts between clinicians, researchers, and patients are essential in advancing our understanding and treatment of this complex brain tumor.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp